AAPL326.57+11.23 (+3.56%) ▲|ABBV255.00+4.09 (+1.63%) ▲|ABT103.57+0.20 (+0.19%) ▲|ACN180.39+2.49 (+1.40%) ▲|ADBE245.07-3.76 (-1.51%) ▼|AMAT457.40+3.39 (+0.75%) ▲|AMD503.03-0.57 (-0.11%) ▼|AMGN384.30+1.83 (+0.48%) ▲|AMT175.60+2.61 (+1.51%) ▲|AMZN256.21+4.32 (+1.72%) ▲|AVGO363.48+2.65 (+0.73%) ▲|AXP324.91+4.18 (+1.30%) ▲|BA208.54+3.69 (+1.80%) ▲|BAC63.78+1.21 (+1.93%) ▲|BKNG174.28+0.37 (+0.21%) ▲|BLK1,080.99+18.45 (+1.74%) ▲|BMY64.05+0.31 (+0.48%) ▲|BNY164.33+1.72 (+1.05%) ▲|BRK-B509.04+2.03 (+0.40%) ▲|C140.92+2.39 (+1.72%) ▲|CAT817.78+12.78 (+1.59%) ▲|CL88.34+0.45 (+0.51%) ▲|CMCSA25.31+0.14 (+0.54%) ▲|COF210.58+3.49 (+1.69%) ▲|COP135.82-1.23 (-0.90%) ▼|COST905.11+2.73 (+0.30%) ▲|CRM247.90+4.80 (+1.97%) ▲|CSCO109.40+1.96 (+1.82%) ▲|CVS96.04+0.75 (+0.79%) ▲|CVX213.29+0.53 (+0.25%) ▲|DE689.56+11.61 (+1.71%) ▲|DHR202.36+1.88 (+0.94%) ▲|DIS106.49+0.64 (+0.61%) ▲|DUK119.81+0.41 (+0.34%) ▲|EMR150.20+1.82 (+1.23%) ▲|FDX314.52+2.70 (+0.86%) ▲|GD355.64+1.35 (+0.38%) ▲|GE328.12+4.00 (+1.23%) ▲|GEV950.00+26.61 (+2.88%) ▲|GILD145.64+0.83 (+0.57%) ▲|GM87.15+1.05 (+1.22%) ▲|GOOG337.20+6.81 (+2.06%) ▲|GOOGL339.35+6.75 (+2.03%) ▲|GS1,037.83+18.10 (+1.77%) ▲|HD311.00+5.30 (+1.73%) ▲|HON203.43+1.25 (+0.62%) ▲|IBM236.56+2.49 (+1.06%) ▲|INTC101.41+1.09 (+1.08%) ▲|INTU318.36+5.59 (+1.79%) ▲|ISRG372.53+12.07 (+3.35%) ▲|JNJ269.03+2.69 (+1.01%) ▲|JPM359.72+6.23 (+1.76%) ▲|KO88.40+0.57 (+0.65%) ▲|LIN464.16+2.54 (+0.55%) ▲|LLY1,127.01+3.74 (+0.33%) ▲|LMT529.21-0.77 (-0.15%) ▼|LOW199.46+2.86 (+1.46%) ▲|LRCX299.94+1.93 (+0.65%) ▲|MA568.38+2.96 (+0.52%) ▲|MCD253.82+0.79 (+0.31%) ▲|MDLZ62.69+0.22 (+0.35%) ▲|MDT92.25+0.63 (+0.69%) ▲|META659.47+15.09 (+2.34%) ▲|MMM163.29+0.43 (+0.26%) ▲|MO69.49+0.73 (+1.06%) ▲|MRK145.06+0.34 (+0.23%) ▲|MS216.60+3.89 (+1.83%) ▲|MSFT496.81+4.37 (+0.89%) ▲|MU978.18+0.77 (+0.08%) ▲|NEE82.95+0.49 (+0.59%) ▲|NFLX76.94+0.93 (+1.22%) ▲|NKE36.94+0.33 (+0.89%) ▲|NOW133.76+2.58 (+1.97%) ▲|NVDA219.49+1.13 (+0.52%) ▲|ORCL156.50+3.33 (+2.17%) ▲|PEP136.99+0.34 (+0.25%) ▲|PFE27.66+0.02 (+0.07%) ▲|PG144.83+1.83 (+1.28%) ▲|PLTR166.88+1.02 (+0.61%) ▲|PM192.68+2.95 (+1.55%) ▲|QCOM181.56+4.68 (+2.65%) ▲|RTX198.38+0.30 (+0.15%) ▲|SBUX99.78+0.56 (+0.56%) ▲|SCHW106.72-0.61 (-0.57%) ▼|SO88.21+0.46 (+0.52%) ▲|SPG205.01+0.27 (+0.13%) ▲|T25.91+0.35 (+1.35%) ▲|TMO609.66+6.51 (+1.08%) ▲|TMUS180.03+2.87 (+1.62%) ▲|TSLA364.96+1.40 (+0.38%) ▲|TXN267.37+8.55 (+3.30%) ▲|UBER72.19-0.37 (-0.51%) ▼|UNH385.23-3.05 (-0.79%) ▼|UNP287.61+1.83 (+0.64%) ▲|UPS100.00+0.03 (+0.03%) ▲|USB62.88+0.47 (+0.75%) ▲|V368.49+1.28 (+0.35%) ▲|VZ50.40+0.43 (+0.86%) ▲|WFC90.41+0.96 (+1.07%) ▲|WMT106.20+0.47 (+0.44%) ▲|XOM165.55+0.32 (+0.19%) ▲|AAPL326.57+11.23 (+3.56%) ▲|ABBV255.00+4.09 (+1.63%) ▲|ABT103.57+0.20 (+0.19%) ▲|ACN180.39+2.49 (+1.40%) ▲|ADBE245.07-3.76 (-1.51%) ▼|AMAT457.40+3.39 (+0.75%) ▲|AMD503.03-0.57 (-0.11%) ▼|AMGN384.30+1.83 (+0.48%) ▲|AMT175.60+2.61 (+1.51%) ▲|AMZN256.21+4.32 (+1.72%) ▲|AVGO363.48+2.65 (+0.73%) ▲|AXP324.91+4.18 (+1.30%) ▲|BA208.54+3.69 (+1.80%) ▲|BAC63.78+1.21 (+1.93%) ▲|BKNG174.28+0.37 (+0.21%) ▲|BLK1,080.99+18.45 (+1.74%) ▲|BMY64.05+0.31 (+0.48%) ▲|BNY164.33+1.72 (+1.05%) ▲|BRK-B509.04+2.03 (+0.40%) ▲|C140.92+2.39 (+1.72%) ▲|CAT817.78+12.78 (+1.59%) ▲|CL88.34+0.45 (+0.51%) ▲|CMCSA25.31+0.14 (+0.54%) ▲|COF210.58+3.49 (+1.69%) ▲|COP135.82-1.23 (-0.90%) ▼|COST905.11+2.73 (+0.30%) ▲|CRM247.90+4.80 (+1.97%) ▲|CSCO109.40+1.96 (+1.82%) ▲|CVS96.04+0.75 (+0.79%) ▲|CVX213.29+0.53 (+0.25%) ▲|DE689.56+11.61 (+1.71%) ▲|DHR202.36+1.88 (+0.94%) ▲|DIS106.49+0.64 (+0.61%) ▲|DUK119.81+0.41 (+0.34%) ▲|EMR150.20+1.82 (+1.23%) ▲|FDX314.52+2.70 (+0.86%) ▲|GD355.64+1.35 (+0.38%) ▲|GE328.12+4.00 (+1.23%) ▲|GEV950.00+26.61 (+2.88%) ▲|GILD145.64+0.83 (+0.57%) ▲|GM87.15+1.05 (+1.22%) ▲|GOOG337.20+6.81 (+2.06%) ▲|GOOGL339.35+6.75 (+2.03%) ▲|GS1,037.83+18.10 (+1.77%) ▲|HD311.00+5.30 (+1.73%) ▲|HON203.43+1.25 (+0.62%) ▲|IBM236.56+2.49 (+1.06%) ▲|INTC101.41+1.09 (+1.08%) ▲|INTU318.36+5.59 (+1.79%) ▲|ISRG372.53+12.07 (+3.35%) ▲|JNJ269.03+2.69 (+1.01%) ▲|JPM359.72+6.23 (+1.76%) ▲|KO88.40+0.57 (+0.65%) ▲|LIN464.16+2.54 (+0.55%) ▲|LLY1,127.01+3.74 (+0.33%) ▲|LMT529.21-0.77 (-0.15%) ▼|LOW199.46+2.86 (+1.46%) ▲|LRCX299.94+1.93 (+0.65%) ▲|MA568.38+2.96 (+0.52%) ▲|MCD253.82+0.79 (+0.31%) ▲|MDLZ62.69+0.22 (+0.35%) ▲|MDT92.25+0.63 (+0.69%) ▲|META659.47+15.09 (+2.34%) ▲|MMM163.29+0.43 (+0.26%) ▲|MO69.49+0.73 (+1.06%) ▲|MRK145.06+0.34 (+0.23%) ▲|MS216.60+3.89 (+1.83%) ▲|MSFT496.81+4.37 (+0.89%) ▲|MU978.18+0.77 (+0.08%) ▲|NEE82.95+0.49 (+0.59%) ▲|NFLX76.94+0.93 (+1.22%) ▲|NKE36.94+0.33 (+0.89%) ▲|NOW133.76+2.58 (+1.97%) ▲|NVDA219.49+1.13 (+0.52%) ▲|ORCL156.50+3.33 (+2.17%) ▲|PEP136.99+0.34 (+0.25%) ▲|PFE27.66+0.02 (+0.07%) ▲|PG144.83+1.83 (+1.28%) ▲|PLTR166.88+1.02 (+0.61%) ▲|PM192.68+2.95 (+1.55%) ▲|QCOM181.56+4.68 (+2.65%) ▲|RTX198.38+0.30 (+0.15%) ▲|SBUX99.78+0.56 (+0.56%) ▲|SCHW106.72-0.61 (-0.57%) ▼|SO88.21+0.46 (+0.52%) ▲|SPG205.01+0.27 (+0.13%) ▲|T25.91+0.35 (+1.35%) ▲|TMO609.66+6.51 (+1.08%) ▲|TMUS180.03+2.87 (+1.62%) ▲|TSLA364.96+1.40 (+0.38%) ▲|TXN267.37+8.55 (+3.30%) ▲|UBER72.19-0.37 (-0.51%) ▼|UNH385.23-3.05 (-0.79%) ▼|UNP287.61+1.83 (+0.64%) ▲|UPS100.00+0.03 (+0.03%) ▲|USB62.88+0.47 (+0.75%) ▲|V368.49+1.28 (+0.35%) ▲|VZ50.40+0.43 (+0.86%) ▲|WFC90.41+0.96 (+1.07%) ▲|WMT106.20+0.47 (+0.44%) ▲|XOM165.55+0.32 (+0.19%) ▲|
21.9 C
New York
Friday, September 11, 2026

Tag: content

newssourceFORcompanyinformationcontent1releasesmarket

AESC and Prevalon Energy Sign 10+ GWh Strategic Supply Agreement to Support Global Energy Storage Growth

SHANGHAI, June 13, 2026 /PRNewswire/ -- AESC, a global leader in high-performance batteries and energy storage systems, and Prevalon Energy, a Mitsubishi Power Americas...

As the Lights Fade, Vivid Sydney 2026 Leaves the City Glowing

Images HERESYDNEY, June 13, 2026 /PRNewswire/ -- Off the back of 23 nights of spectacular sights, events and experiences, Vivid Sydney switches off its...

YEEDI Delivers Lowest-Ever Pricing on Self-Cleaning Roller Mop Robot Vacuums With Early Prime Day Deals

Starting June 13, M14 PLUS and S14 PLUS Drop to $399.99, Bringing Advanced Self-Cleaning Roller Mop Technology Into the Sub-$400 SegmentSAN FRANCISCO, June 13,...

As the Lights Fade, Vivid Sydney 2026 Leaves the City Glowing

Images HERESYDNEY, June 13, 2026 /PRNewswire/ -- Off the back of 23 nights of spectacular sights, events and experiences, Vivid Sydney switches off its...

VEVOR Launches “Beat the Heat at Home” Summer Comfort Lineup for Outdoor Living

HOUSTON, June 13, 2026 /PRNewswire/ -- As summer temperatures climb, staying cool at home shouldn't require a sky-high electric bill, a cooler full of...

As the Lights Fade, Vivid Sydney 2026 Leaves the City Glowing

Images HERESYDNEY, June 13, 2026 /CNW/ -- Off the back of 23 nights of spectacular sights, events and experiences, Vivid Sydney switches off its...

Hozpitality Celebrates Hospitality Excellence at the Middle East Chef Excellence Awards, F&B Excellence Awards and Leaders Powerlist 2026

DUBAI, UAE, June 13, 2026 /PRNewswire/ -- Hozpitality Group successfully hosted the 9th Middle East Chef Excellence Awards 2026 alongside the 4th Middle East...

Hozpitality Celebrates Hospitality Excellence at the Middle East Chef Excellence Awards, F&B Excellence Awards and Leaders Powerlist 2026

DUBAI, UAE, June 13, 2026 /PRNewswire/ -- Hozpitality Group successfully hosted the 9th Middle East Chef Excellence Awards 2026 alongside the 4th Middle East...

GOOD WORKS, GIVING, AND GLAMOUR SHINE AT NORTH SHORE ANIMAL LEAGUE AMERICA’S RESCUE GALA CELEBRATING ANIMAL RESCUE AND ADOPTION

Attendees Included Event Chairperson Beth Stern, Event Host Will Ganss, Event Entertainer Joshua Radin, Liz Gillies, The Dogist (Elias Weiss Friedman,) and Others.  Proceeds...

 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

 -- Patients with PWS treated with setmelanotide therapy (N=17) achieved clinically meaningful BMI or BMI z-score reductions, reductions in fat mass with preservation of lean mass, and improvements in hyperphagia and anxiety measures --   

-- Positive results reinforce rationale for Phase 3 development of MC4R agonism in PWS --

New TALVEY®▼(talquetamab) plus daratumumab data demonstrate the potential strength of a novel bispecific combination in earlier-line relapsed or refractory multiple myeloma

BEERSE, BELGIUM, June 13, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced results from the investigational Phase 3 MonumenTAL-3 study.1 The results showed that TALVEY® (talquetamab), a GPRC5D bispecific antibody, in combination with daratumumab with or without pomalidomide demonstrated significant reduction in the risk of disease progression or death of up to 72.0%, and clinically meaningful reduction of up to 53.0% in the risk of death, compared to the standard regimen of daratumumab, pomalidomide, and dexamethasone (DPd) in patients with relapsed or refractory multiple myeloma (RRMM).1 Results showed a progression-free survival (PFS) rate of up to 81.3% versus standard of care (51.2%) and an overall survival (OS) rate of up to 89.2% versus standard of care (79.1%) at 24 months.1  

New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myeloma

TALVEY® plus DARZALEX FASPRO® with or without pomalidomide showed progression-free survival of up to 81% and overall survival of up to 89% at 24 monthsMonumenTAL-3 is the...

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies , a global provider of IT solutions and services, today opened a...

Hexaware Expands Presence in Gujarat with New Delivery Center at GIFT City

MUMBAI, India, LONDON and ISELIN, N.J., June 13, 2026 /PRNewswire/ -- Hexaware Technologies , a global provider of IT solutions and services, today opened a...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsContent

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers